Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways
- PMID: 15101819
- PMCID: PMC1133884
- DOI: 10.1042/BJ20040356
Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways
Erratum in
- Biochem J. 2004 Nov 1;383(Pt. 3):599
Abstract
Cardiac hypertrophy and remodelling in chagasic disease might be associated with mitochondrial dysfunction. In the present study, we characterized the cardiac metabolic responses to Trypanosoma cruzi infection and progressive disease severity using a custom-designed mitoarray (mitochondrial function-related gene array). Mitoarrays consisting of known, well-characterized mitochondrial function-related cDNAs were hybridized with 32P-labelled cDNA probes generated from the myocardium of mice during immediate early, acute and chronic phases of infection and disease development. The mitoarray successfully identified novel aspects of the T. cruzi-induced alterations in the expression of the genes related to mitochondrial function and biogenesis that were further confirmed by real-time reverse transcriptase-PCRs. Of note is the up-regulation of transcripts essential for fatty acid metabolism associated with repression of the mRNAs for pyruvate dehydrogenase complex in infected hearts. We observed no statistically significant changes in mRNAs for the enzymes of tricarboxylic acid cycle. These results suggest that fatty acid metabolism compensates the pyruvate dehydrogenase complex deficiencies for the supply of acetyl-CoA for a tricarboxylic acid cycle, and chagasic hearts may not be limited in reduced energy (NADH and FADH2). The observation of a decrease in mRNA level for several subunits of the respiratory chain complexes by mitoarray as well as global genome analysis suggests a limitation in mitochondrial oxidative phosphorylation-mediated ATP-generation capacity as the probable basis for cardiac homoeostasis in chagasic disease.
Figures




Similar articles
-
Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant response.J Am Heart Assoc. 2012 Dec;1(6):e003855. doi: 10.1161/JAHA.112.003855. Epub 2012 Dec 19. J Am Heart Assoc. 2012. PMID: 23316324 Free PMC article.
-
Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development.Biochim Biophys Acta. 2003 Jul 14;1638(2):106-20. doi: 10.1016/s0925-4439(03)00060-7. Biochim Biophys Acta. 2003. PMID: 12853116
-
Oxidative modification of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection.Free Radic Biol Med. 2004 Dec 15;37(12):2072-81. doi: 10.1016/j.freeradbiomed.2004.09.011. Free Radic Biol Med. 2004. PMID: 15544925
-
Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease.Am J Pathol. 2006 Dec;169(6):1953-64. doi: 10.2353/ajpath.2006.060475. Am J Pathol. 2006. PMID: 17148660 Free PMC article.
-
Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development.Biochim Biophys Acta. 2004 Jun 28;1689(2):162-73. doi: 10.1016/j.bbadis.2004.03.005. Biochim Biophys Acta. 2004. PMID: 15196597
Cited by
-
Chemotherapeutic efficacy of phosphodiesterase inhibitors in chagasic cardiomyopathy.JACC Basic Transl Sci. 2016 Jun;1(4):235-250. doi: 10.1016/j.jacbts.2016.04.005. JACC Basic Transl Sci. 2016. PMID: 27747306 Free PMC article.
-
Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.Clin Vaccine Immunol. 2008 Aug;15(8):1158-64. doi: 10.1128/CVI.00144-08. Epub 2008 Jun 11. Clin Vaccine Immunol. 2008. PMID: 18550728 Free PMC article.
-
Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant response.J Am Heart Assoc. 2012 Dec;1(6):e003855. doi: 10.1161/JAHA.112.003855. Epub 2012 Dec 19. J Am Heart Assoc. 2012. PMID: 23316324 Free PMC article.
-
Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice.NPJ Vaccines. 2023 Dec 16;8(1):188. doi: 10.1038/s41541-023-00782-z. NPJ Vaccines. 2023. PMID: 38104118 Free PMC article.
-
Regulation of pyruvate metabolism in metabolic-related diseases.Rev Endocr Metab Disord. 2014 Mar;15(1):99-110. doi: 10.1007/s11154-013-9284-2. Rev Endocr Metab Disord. 2014. PMID: 24214243 Review.
References
-
- World Health Organization. Chagas disease: tropical diseases progress in research, 1997–1998. WHO Techn. Rep. Series. 1999. p. 1.
-
- Moncayo A. Chagas disease: epidemiology and prospects for interruption of transmission in the Americas. World Health Stat. Q. 1992;45:276–279. - PubMed
-
- Higuchi M. L., Benvenuti L. A., Martins Reis M., Metzger M. Pathophysiology of the heart in Chagas’ disease: current status and new developments. Cardiovasc. Res. 2003;60:96–107. - PubMed
-
- Garg N., Popov V. L., Papaconstantinou J. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim. Biophys. Acta. 2003;1638:106–120. - PubMed
-
- Mukherjee S., Belbin T. J., Spray D. C., Lacobas D. A., Weiss L. M., Kitsis R. N., et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol. Res. 2003;91:187–196. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical